Malignant Urinary Tract Neoplasm — Research

Malignant Urinary Tract Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-12	559	`("Malignant Urinary Tract Neoplasm"[tiab] OR "Urinary Tract Cancer"[tiab] OR "Malignant Urinary Tract Tumor"[tiab])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	185	`("Malignant Urinary Tract Neoplasm"[tiab] OR "Urinary Tract Cancer"[tiab] OR "Malignant Urinary Tract Tumor"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	27	`("Malignant Urinary Tract Neoplasm"[tiab] OR "Urinary Tract Cancer"[tiab] OR "Malignant Urinary Tract Tumor"[tiab]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (152)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–50 of 152 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Introducing "HEDGE": sequential intravesical gemcitabine-based thermochemotherapy (HIVEC) plus docetaxel as a potential novel bladder-sparing strategy for BCG-unresponsive non-muscle-invasive bladder cancer.
Lampros Mitrakas, Athanasios Zisopoulos, Konstantinos Dimitropoulos et al. · Arch Ital Urol Androl · Sep 25, 2026 · PMID 42714388 · candidate dictionary pubmed
Phenanthrene Derivatives from Arundina graminifolia Inhibit the Migration and Proliferation of Human Bladder Cancer Cells.
Xingyu Zhang, Songlin Yu, Shiquan Liu et al. · Anticancer Agents Med Chem · Sep 25, 2026 · PMID 42786873 · candidate dictionary pubmed
Re: Valentina Tateo, Giuseppe Basile, Patrizia Giannatempo, et al. Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer. Eur Urol 2026;90:7-12.
Ahmed M Elalfy · Eur Urol · Sep 25, 2026 · PMID 42791106